Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy
Go back to Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 216.12 +6.38 (3.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $209.74 | 52 Week High | $333.65 | |||
| Open | $212.74 | 52 Week Low | $223.02 | |||
| Day High | $219.02 | P/E | 27.67 | |||
| Day Low | $210.75 | EPS | $7.81 | |||
| Volume | 1,155,166 | |||||

